HYLACROSS
Live / Applied — Second extension granted (statement of use) (as of 16 Jul 2025)
What this means for you
Not registered yet, but its 15 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98451137
- Mark type
- Stylized text
- Filed
- 15 Mar 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations to treat dermatological conditions; medical preparations consisting of a dermatological preparation, individually or in a set, namely, pre-filled syringes for filling lines, wrinkles and lips, for tightening the face and body and for rejuvenating the skin; medicinal preparations for the treatment of dermatological conditions; injectable pharmaceutical products to treat dermatological conditions; injectable dermal fillers; pharmaceutical preparations for skin care
Owner
- Allergan, Inc., North Chicago, IL, US
- Allergan, Inc., North Chicago, IL, US
Prosecution history
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 2 GRANTED
- 16 Jul 2025 — SOU EXTENSION 2 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 29 May 2025 — SOU EXTENSION 1 GRANTED
- 28 May 2025 — SOU EXTENSION 1 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Apr 2025 — ASSIGNED TO EXAMINER
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION
- 02 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE